ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Now I have good context. Let me write the article focusing on the most interesting analyst activity, particularly UBS's aggressive upgrade campaign and the semiconductor strength:

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Now I have good context. Let me write the article focusing on the most interesting analyst activity, particularly UBS's aggressive upgrade campaign and the semiconductor strength:

UBS Boosts Chip Targets

TXN Texas Instruments grabbed a $295 target from UBS today. Timothy Arcuri lifted his price 13.5% from $260 showing fresh conviction in analog chips. The $295B semiconductor giant held buy ratings across Wall Street.

UBS dominated Wednesday's analyst activity with upgrades spanning five sectors. The Swiss bank raised targets on MAS Masco to $97. TPR Tapestry climbed to $142. RJF Raymond James Financial hit $166 up from $158.

GEV GE Vernova consensus target surged 8.7% to $1,105.53. The $125B power equipment maker absorbed bullish momentum as analysts chased industrial strength. The stock held 28 hold ratings showing cautious positioning despite target hikes.

TSLA Tesla rose to $364 from $352 per UBS. Joseph Spak maintained hold as the automaker navigated production questions. CRWD CrowdStrike consensus ticked to $491.14 showing cybersecurity resilience.

Semiconductor names dominated positive revisions. NXPI NXP Semiconductors consensus climbed to $258.84 as chip demand held firm. UBS led the upgrade wave while consensus targets rose across industrials and tech.

WST West Pharmaceutical gained analyst support rising to $323.08. The healthcare equipment maker held momentum as defensive sectors attracted flows.

How this article was generated

Generated
23 Apr 2026, 20:22
Prompt version
migrated
Data sources
Analyst consensusAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.